|
StandoutStocks.com: "Stocks that Standout" picks for today are: ACUR, EDWY, LIFE, VRSN
Jul 02, 2009 (M2 PRESSWIRE via COMTEX) --
StandoutStocks.com "Stocks that Standout" picks for today are: Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), eDOORWAYS Corporation (PINKSHEETS: EDWY), Life Technologies Corporation (NASDAQ: LIFE), VeriSign, Inc. (NASDAQ: VRSN) <<
<<
Visit Us On Twitter and Facebook: http://twitter.com/StandoutStocks http://www.facebook.com/people/Standout-Stocks/547603354
<<
<<
Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at www.Standoutstocks.com
<<
<<
Jul 2, 2009 -- Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding the New Drug Application (NDA) for Acurox (oxycodone HC1, USP and niacin, USP) Tablets CII, an immediate release product intended for the relief of moderate-to-severe pain.
The Complete Response Letter raises issues regarding the potential abuse deterrent benefits of Acurox(R). Acura and King are currently evaluating the FDA's Complete Response Letter, and at this stage believe they can respond to the issues raised without conducting any additional studies. The Companies plan to meet with the FDA following submission of their response.
About Acurox Tablets
Acurox is a patented, orally administered, immediate release tablet containing oxycodone HCl as its sole active analgesic ingredient with a proposed indication for the relief of moderate-to-severe pain. Acurox utilizes Acura's proprietary Aversion Technology, which is designed to deter misuse and abuse by intentional swallowing of excess quantities of tablets, intravenous injection of dissolved tablets and nasal snorting of crushed tablets. The Acurox(R) Tablets NDA was originally accepted for filing by FDA earlier this year with a priority review classification.
About Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of Aversion(R) (abuse deterrent) Technology product candidates and other innovative abuse deterrent technologies. Acura and King jointly developed Acurox(R) Tablets and are developing three additional opioid analgesic product candidates utilizing Aversion(R) Technology pursuant to a 2007 License, Development and Commercialization Agreement.
About King Pharmaceuticals, Inc.
King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products and technologies that complement the Company's focus in specialty-driven markets, particularly neuroscience and hospital. King's wholly-owned subsidiary, Alpharma, Inc., is also a leader in the development, registration, manufacturing and marketing of pharmaceutical products for food producing animals.
<<
<<
Jul 2, 2009 -- eDOORWAYS Corporation (PINKSHEETS: EDWY) makes the following statement:
On the last shareholder conference call, the company was asked if we would be willing to make the eDOORWAYS platform and the SOLVE doorway available for demonstration. At that time, our Chairman and CEO, Mr. Gary Kimmons, advised that making SOLVE available to the public before its scheduled release introduces undue risk associated with losing our competitive advantage in the marketplace.
Nevertheless, as a participant in our conference call noted, "seeing is believing," and many of you are demanding to see what we've achieved. This has created an interesting dilemma -- if we unveil SOLVE, we risk ultimately hurting shareholder value by allowing competitors insight into the mechanics of the platform. We're almost positive that any reasonable shareholder would not want that. Yet, if we continue to hold it close until the soft launch, it is clear that many of you, our shareholders, will continue to question the veracity and authenticity of our effort. The impasse this creates is detrimental to all of us -- and it's negatively affecting our value in the marketplace.
We simply cannot let this continue to unjustly happen. As an act of mutual good-faith, we are prepared to act immediately by offering to make the SOLVE doorway available for shareholder inspection and review via a "live walk-through" conducted by our technology consultants. The walk-through is available to us now since we've used it for past presentations to private capital sources. However, exactly how it is we can implement the presentations to the public with a reasonable degree of security must still be resolved.
It's our intention to get back to you as soon as possible with a plan that can work whereby the walk-through is made available within the month. This should only take a few business days. At that time, we will announce the viewing date(s), our plan for certifying participants and the forum in which we intend to conduct this event. Regardless, we see no reason why the presentation(s) cannot be conducted this month.
To conclude, we understand that our shareholders are excited to view a demonstration of the platform and celebrate what the company has achieved. And it is because we value you, our shareholders, we will proactively strive to meet your stated needs and expectations.
Your patience and understanding regarding this sensitive issue is sincerely appreciated!
<<
<<
Jul 2, 2009 -- Life Technologies Corporation (NASDAQ: LIFE) announced today it will report its second quarter 2009 financial results on Tuesday, July 28, 2009, after market close. The company will also hold a conference call on the same day at 4:30 p.m. EDT to discuss operating results.
The webcast can be accessed through the investor relations page of the Life Technologies' website. Alternatively, callers may listen to the live conference call by dialing 866.543.6405 (domestic) or 617.213.8897 (international) and use passcode 98399425. A replay of the webcast will be available on the Company's website through Tuesday, August 18, 2009.
About Life Technologies
Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc.
<<
<<
Jul 2, 2009 -- The inventive Cart Whisperer marketing campaign from VeriSign, Inc. (NASDAQ: VRSN), the leading provider of Internet infrastructure services for the networked world, and creative group McCann Erickson, has won the 30th Annual Telly Awards' 2009 Silver Telly award for best Internet/online business-to-business commercial campaign.
The Telly Awards competition is the premier award honoring outstanding local, regional, and cable TV commercials and programs, the finest video and film productions, and online film and video. The Telly Awards annually showcases the best work of the most respected advertising agencies, production companies, television stations, cable operators, interactive agencies, and corporations in the world. Winners are chosen annually from more than 13,000 entries from all 50 states and countries around the world.
Launched in February 2008, the Cart Whisperer is a campaign based on the personal crusade of Liberty Fillmore, a.k.a. the Cart Whisperer, and offers a light hearted look at a common online business pain point: abandoned shopping carts. The Cart Whisperer includes a Web site (www.nomoreabandonedcarts.com) which features videos, photos and poems depicting Liberty's life as a rescuer of abandoned shopping carts. The successful campaign garnered more than 5 million views on YouTube, attracted nearly 123,000 visits to www.nomoreabandonedcarts.com, and acquired more than 400 friends on MySpace and Facebook combined.
"We are ecstatic and honored to be recognized by the Telly Awards for the Cart Whisperer campaign," said Marianna Peyzner, SSL product marketing manager at VeriSign. "The objective of the Cart Whisperer campaign was to show online retailers how to prevent cart abandonment by letting consumers know it is safe to shop with the Internet's most visible Web site security indicator -- the green browser bar of Extended Validation SSL Certificates."
In June 2008, the Cart Whisperer was inducted into the MarketingSherpa Viral Marketing Hall of Fame. Most recently in 2009, the campaign received an Internet Advertising Competition (IAC) Award for Outstanding Achievement in Internet Advertising in the "Best Computer: Software Web Sites" category. The campaign also helped VeriSign win the 2008 Online Safety Leadership Award by the Authentication and Online Trust Alliance (AOTA) for exceptional commitment to improving online safety.
About VeriSign
VeriSign, Inc. is the trusted provider of Internet infrastructure services for the networked world. Billions of times each day, VeriSign helps companies and consumers all over the world engage in communications and commerce with confidence.
<<
<<
About Standoutstocks.com
Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.
Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at www.Standoutstocks.com and select the "join now" button.
Join us at www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.
Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
Visit us for a full Disclaimer at: www.standoutstocks.com/disclaimer.aspx
CONTACT: Standoutstocks.com
e-mail: info@standoutstocks.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
[ Back To Homepage ]
|
